Benzinga - by Surbhi Jain, .
Visa Inc (NYSE:V), will be reporting its second-quarter earnings on Tuesday. Wall Street expects $2.44 in EPS and $8.62 billion in revenues as the company reports after market hours.
The company has been delivering an earnings beat over the last four quarters. The stock experienced significant gains from October 2023 to March 2024. However, it has fallen more than 7% since March 21, which has reduced its year-to-date performance to just 3.62%.
The stock appears to have been impacted by:
Also Read: Understanding Visa’s Position In Financial Services Industry Compared To Competitors
Let’s look at the technical setup of the stock, as the company heads into reporting Q2 earnings.
Visa Stock Technical Setup Ahead Of Q2 Earnings
Chart: Benzinga Pro
With a share price of $269.78, below the 8-day simple moving average of $271.29, 20-day SMA of $276.25, and 50-day SMA of $279.46, the technical signals point towards a bearish sentiment.
However, the stock’s price exceeding the 200-day simple moving average of $255.79 provides a bullish indication.
Chart: Benzinga Pro
The Moving Average Convergence Divergence (MACD) indicator stands at -2.54, reinforcing the bearish sentiment, while the Relative Strength Index (RSI) of 34.6 sees the stock nearing oversold conditions (
The Bollinger Bands also echo the bearish sentiment, with the price trading in the lower band since March 21.
Visa Analysts Consensus Ratings
Ratings & Consensus Estimates:However, the last three ratings on the stock from analysts who reviewed the stock on or after March 27, have an average price target of $301.67 between Baird, TD Cowen, and Mizuho. There’s an implied 12.02% upside for Visa stock from these 3 analyst ratings.
Price Action: Visa stock was up 0.04% to $269.89 during early morning trading on Monday.
Read Next: Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts
Photo: Shutterstock
Latest Ratings for V
Jan 2022 | Barclays | Maintains | Overweight | |
Jan 2022 | Wedbush | Maintains | Outperform | |
Jan 2022 | Raymond James | Maintains | Outperform |
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.